Trial Profile
A Multi-center, Randomized, Vehicle-controlled, Double-blind, Study to Evaluate the Safety and Efficacy of Epiduo (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Administered Once Daily for the Treatment of Subjects 9 to 11 Years of Age With Acne Vulgaris
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Feb 2021
Price :
$35
*
At a glance
- Drugs Adapalene/benzoyl peroxide (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- Sponsors Galderma
- 14 Apr 2014 New trial record